Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Outcomes After Onyx Embolization as Primary Treatment for Cranial Dural Arteriovenous Fistula in the Past Decade.

Moenninghoff C, Pohl E, Deuschl C, Wrede K, Jabbarli R, Radbruch A, Sure U, Forsting M, Wanke I.

Acad Radiol. 2019 Aug 21. pii: S1076-6332(19)30370-8. doi: 10.1016/j.acra.2019.07.021. [Epub ahead of print]

PMID:
31445824
2.

Dural venous sinus stenting as a stand-alone treatment for spontaneous skull base CSF leak secondary to venous pseudotumor cerebri syndrome.

San Millán D, Hallak B, Wanke I, Wetzel S, Van Dommelen K, Rüfenacht D, Gailloud P.

Neuroradiology. 2019 Sep;61(9):1103-1106. doi: 10.1007/s00234-019-02251-8. Epub 2019 Jul 27.

PMID:
31352494
3.

Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factors.

Dammann P, Wittek P, Darkwah Oppong M, Hütter BO, Jabbarli R, Wrede K, Wanke I, Mönninghoff C, Kaier K, Frank B, Müller O, Kleinschnitz C, Forsting M, Sure U.

Ther Adv Neurol Disord. 2019 Mar 8;12:1756286419833492. doi: 10.1177/1756286419833492. eCollection 2019.

4.

Feasibility of intra-arterial chemotherapy for retinoblastoma: experiences in a large single center cohort study.

Stenzel E, Göricke S, Temming P, Biewald E, Zülow S, Göbel J, Wanke I, Umutlu L, Kleinschnitz C, Bornfeld N, Forsting M, Radbruch A, Mönninghoff C.

Neuroradiology. 2019 Mar;61(3):351-357. doi: 10.1007/s00234-019-02153-9. Epub 2019 Jan 14.

PMID:
30643921
5.

Effectiveness of Endovascular Recanalization Treatment for M2 Segment Occlusion: Comparison Between Intracranial ICA, M1, and M2 Segment Thrombectomy.

Goebel J, Stenzel E, Wanke I, Paech D, Koehrmann M, Kleinschnitz C, Forsting M, Radbruch A, Moenninghoff C.

Acad Radiol. 2019 Oct;26(10):e298-e304. doi: 10.1016/j.acra.2018.11.019. Epub 2018 Dec 24.

PMID:
30587388
6.

Automated ASPECT rating: comparison between the Frontier ASPECT Score software and the Brainomix software.

Goebel J, Stenzel E, Guberina N, Wanke I, Koehrmann M, Kleinschnitz C, Umutlu L, Forsting M, Moenninghoff C, Radbruch A.

Neuroradiology. 2018 Dec;60(12):1267-1272. doi: 10.1007/s00234-018-2098-x. Epub 2018 Sep 15.

PMID:
30219935
7.

Stent-assisted treatment of ruptured intracranial aneurysms in the acute phase: A single center experience.

Ho MJ, Göricke SL, Mummel P, Mönninghoff C, Wrede K, Wanke I.

eNeurologicalSci. 2018 Jan 28;10:31-36. doi: 10.1016/j.ensci.2018.01.001. eCollection 2018 Mar.

8.

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.

Niessner H, Sinnberg T, Kosnopfel C, Smalley KSM, Beck D, Praetorius C, Mai M, Beissert S, Kulms D, Schaller M, Garbe C, Flaherty KT, Westphal D, Wanke I, Meier F.

Clin Cancer Res. 2017 Oct 15;23(20):6203-6214. doi: 10.1158/1078-0432.CCR-17-0098. Epub 2017 Jul 19.

9.

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.

Niessner H, Kosnopfel C, Sinnberg T, Beck D, Krieg K, Wanke I, Lasithiotakis K, Bonin M, Garbe C, Meier F.

Exp Dermatol. 2017 Jul;26(7):598-606. doi: 10.1111/exd.13372.

PMID:
28423208
10.

Multiple cerebral arterio-venous malformations: impact of multiplicity and hemodynamics on treatment strategies.

Stein KP, Wanke I, Oezkan N, Zhu Y, Sandalcioglu IE, Forsting M, Sure U.

Acta Neurochir (Wien). 2016 Dec;158(12):2399-2407. Epub 2016 Oct 20.

PMID:
27766428
11.

Can we now dispense with DSA in the evaluation of aneurysm occlusion even in the most crucial first follow-up after endovascular treatment?

Gramsch C, Zülow S, Nensa F, Maderwald S, Göricke S, Ringelstein A, Müller O, Sure U, Wanke I, Schlamann M.

Clin Neurol Neurosurg. 2016 Oct;149:136-42. doi: 10.1016/j.clineuro.2016.08.005. Epub 2016 Aug 2.

PMID:
27522540
12.

A novel, non-adhesive, precipitating liquid embolic implant with intrinsic radiopacity: feasibility and safety animal study.

Kulcsár Z, Karol A, Kronen PW, Svende P, Klein K, Jordan O, Wanke I.

Eur Radiol. 2017 Mar;27(3):1248-1256. doi: 10.1007/s00330-016-4463-7. Epub 2016 Jun 14.

PMID:
27300197
13.

Brain herniations into arachnoid granulations: about 68 cases in 38 patients and review of the literature.

Malekzadehlashkariani S, Wanke I, Rüfenacht DA, San Millán D.

Neuroradiology. 2016 May;58(5):443-57. doi: 10.1007/s00234-016-1662-5. Epub 2016 Feb 17. Review.

PMID:
26886861
14.

Associated Aneurysms in Infratentorial Arteriovenous Malformations: Role of Aneurysm Size and Comparison with Supratentorial Lesions.

Stein KP, Wanke I, Forsting M, Oezkan N, Huetter BO, Sandalcioglu IE, Sure U.

Cerebrovasc Dis. 2016;41(5-6):219-25. doi: 10.1159/000443540. Epub 2016 Jan 22.

PMID:
26795269
15.

Safety and effectiveness of large volume coils in the treatment of small aneurysms.

Kulcsár Z, Wanke I, Rüfenacht D, Wetzel SG, Göricke S, Kolia K, Quarfordt S, Calvert J, Hawk H, Baxter B.

J Neurointerv Surg. 2016 Dec;8(12):1260-1263. doi: 10.1136/neurintsurg-2015-012100. Epub 2016 Jan 20.

PMID:
26790826
16.

European Society of Minimally Invasive Neurological Therapy (ESMINT).

Wanke I, Rüfenacht DA.

Clin Neuroradiol. 2015 Oct;25 Suppl 2:135-6. doi: 10.1007/s00062-015-0452-5. Epub 2015 Aug 28. Review. German. No abstract available.

PMID:
26314309
17.

The Dural AV-Fistula (DAVF), the Most Frequent Acquired Vascular Malformation of the Central Nervous System (CNS).

Wanke I, Rüfenacht DA.

Clin Neuroradiol. 2015 Oct;25 Suppl 2:325-32. doi: 10.1007/s00062-015-0449-0. Epub 2015 Aug 26. Review.

PMID:
26308245
18.

The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.

Etminan N, Brown RD Jr, Beseoglu K, Juvela S, Raymond J, Morita A, Torner JC, Derdeyn CP, Raabe A, Mocco J, Korja M, Abdulazim A, Amin-Hanjani S, Al-Shahi Salman R, Barrow DL, Bederson J, Bonafe A, Dumont AS, Fiorella DJ, Gruber A, Hankey GJ, Hasan DM, Hoh BL, Jabbour P, Kasuya H, Kelly ME, Kirkpatrick PJ, Knuckey N, Koivisto T, Krings T, Lawton MT, Marotta TR, Mayer SA, Mee E, Pereira VM, Molyneux A, Morgan MK, Mori K, Murayama Y, Nagahiro S, Nakayama N, Niemelä M, Ogilvy CS, Pierot L, Rabinstein AA, Roos YB, Rinne J, Rosenwasser RH, Ronkainen A, Schaller K, Seifert V, Solomon RA, Spears J, Steiger HJ, Vergouwen MD, Wanke I, Wermer MJ, Wong GK, Wong JH, Zipfel GJ, Connolly ES Jr, Steinmetz H, Lanzino G, Pasqualin A, Rüfenacht D, Vajkoczy P, McDougall C, Hänggi D, LeRoux P, Rinkel GJ, Macdonald RL.

Neurology. 2015 Sep 8;85(10):881-9. doi: 10.1212/WNL.0000000000001891. Epub 2015 Aug 14.

19.

Single center experience with treatment of spinal dural arteriovenous fistulas.

Özkan N, Kreitschmann-Andermahr I, Goerike SL, Wrede KH, Kleist B, Stein KP, Gembruch O, Sandalcioglu IE, Wanke I, Sure U.

Neurosurg Rev. 2015 Oct;38(4):683-92. doi: 10.1007/s10143-015-0645-z. Epub 2015 Jul 17.

PMID:
26178237
20.

Are transversal MR images sufficient to distinguish persons with mild cognitive impairment from healthy controls?

Mönninghoff C, Dlugaj M, Kraff O, Geisel MH, Jöckel KH, Erbel R, Weimar C, Wanke I; Heinz Nixdorf Recall Study Investigative Group.

Acad Radiol. 2015 Sep;22(9):1172-80. doi: 10.1016/j.acra.2015.04.008. Epub 2015 Jul 7.

PMID:
26162248
21.

Value of DSA in the diagnostic workup of pulsatile tinnitus.

Deuschl C, Göricke S, Gramsch C, Özkan N, Lehnerdt G, Kastrup O, Ringelstein A, Wanke I, Forsting M, Schlamann M.

PLoS One. 2015 Feb 17;10(2):e0117814. doi: 10.1371/journal.pone.0117814. eCollection 2015.

22.

Associated aneurysms in supratentorial arteriovenous malformations: impact of aneurysm size on haemorrhage.

Stein KP, Wanke I, Forsting M, Zhu Y, Moldovan AS, Dammann P, Sandalcioglu IE, Sure U.

Cerebrovasc Dis. 2015;39(2):122-9. doi: 10.1159/000369958. Epub 2015 Jan 31.

PMID:
25660640
23.

Outcome for unruptured middle cerebral artery aneurysm treatment: surgical and endovascular approach in a single center.

Dammann P, Schoemberg T, Müller O, Özkan N, Schlamann M, Wanke I, Sandalcioglu IE, Forsting M, Sure U.

Neurosurg Rev. 2014 Oct;37(4):643-51. doi: 10.1007/s10143-014-0563-5. Epub 2014 Jul 9.

PMID:
25005630
24.

Posterior fossa arterio-venous malformations: current multimodal treatment strategies and results.

Stein KP, Wanke I, Schlamann M, Dammann P, Moldovan AS, Zhu Y, Sure U, Sandalcioglu IE.

Neurosurg Rev. 2014 Oct;37(4):619-28. doi: 10.1007/s10143-014-0551-9. Epub 2014 May 9.

PMID:
24811220
25.

Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies.

Di Marco LY, Marzo A, Muñoz-Ruiz M, Ikram MA, Kivipelto M, Ruefenacht D, Venneri A, Soininen H, Wanke I, Ventikos YA, Frangi AF.

J Alzheimers Dis. 2014;42(1):119-35. doi: 10.3233/JAD-132225. Review.

PMID:
24799342
26.

Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group.

Etminan N, Beseoglu K, Barrow DL, Bederson J, Brown RD Jr, Connolly ES Jr, Derdeyn CP, Hänggi D, Hasan D, Juvela S, Kasuya H, Kirkpatrick PJ, Knuckey N, Koivisto T, Lanzino G, Lawton MT, LeRoux P, McDougall CG, Mee E, Mocco J, Molyneux A, Morgan MK, Mori K, Morita A, Murayama Y, Nagahiro S, Pasqualin A, Raabe A, Raymond J, Rinkel GJ, Rüfenacht D, Seifert V, Spears J, Steiger HJ, Steinmetz H, Torner JC, Vajkoczy P, Wanke I, Wong GK, Wong JH, Macdonald RL.

Stroke. 2014 May;45(5):1523-30. doi: 10.1161/STROKEAHA.114.004519. Epub 2014 Mar 25.

PMID:
24668202
27.

Processing of laminin α chains generates peptides involved in wound healing and host defense.

Senyürek I, Kempf WE, Klein G, Maurer A, Kalbacher H, Schäfer L, Wanke I, Christ C, Stevanovic S, Schaller M, Rousselle P, Garbe C, Biedermann T, Schittek B.

J Innate Immun. 2014;6(4):467-84. doi: 10.1159/000357032. Epub 2014 Jan 18.

28.

Treatment of complex neurovascular lesions: an interdisciplinary angio suite approach.

Dammann P, Breyer T, Wrede KH, Stein KP, Wanke I, Grams AE, Gizewski ER, Schlamann M, Forsting M, Sandalcioglu IE, Sure U.

Ther Adv Neurol Disord. 2014 Jan;7(1):60-70. doi: 10.1177/1756285613496861.

29.

Ruptured, fusiform, distal lenticulostriate aneurysm causing intraventricular haemorrhage in a patient with antiphospholipid-negative Sneddon's syndrome.

Killeen T, Wanke I, Mangiardi J, Cesnulis E.

Clin Neurol Neurosurg. 2014 Jan;116:80-2. doi: 10.1016/j.clineuro.2013.11.009. Epub 2013 Nov 18. No abstract available.

PMID:
24300743
30.

Benefit of second catheter angiography in patients with nontraumatic subarachnoidal hemorrhage.

Ringelstein A, Mueller O, Goericke SL, Moenninghoff C, Sure U, Wanke I, Forsting M, Schlamann M.

Clin Neuroradiol. 2015 Mar;25(1):13-7. doi: 10.1007/s00062-013-0271-5. Epub 2013 Nov 28.

PMID:
24287969
31.

Silent embolism after stent-assisted coiling of cerebral aneurysms: diffusion-weighted MRI study of 75 cases.

Hahnemann ML, Ringelstein A, Sandalcioglu IE, Goericke S, Moenninghoff C, Wanke I, Forsting M, Sure U, Schlamann M.

J Neurointerv Surg. 2014 Jul;6(6):461-5. doi: 10.1136/neurintsurg-2013-010820. Epub 2013 Aug 8.

PMID:
23929549
32.

A new-generation, low-permeability flow diverting device for treatment of saccular aneurysms.

Mallik AS, Nuss K, Kronen PW, Klein K, Karol A, von Rechenberg B, Rüfenacht DA, Wanke I, Kulcsár Z.

Eur Radiol. 2014 Jan;24(1):12-8. doi: 10.1007/s00330-013-2970-3. Epub 2013 Jul 24.

PMID:
23881302
33.

Intramedullary spinal cord astrocytomas: the influence of localization and tumor extension on resectability and functional outcome.

Ardeshiri A, Chen B, Hütter BO, Oezkan N, Wanke I, Sure U, Sandalcioglu IE.

Acta Neurochir (Wien). 2013 Jul;155(7):1203-7. doi: 10.1007/s00701-013-1762-5. Epub 2013 May 23.

PMID:
23700256
34.

Automatic segmentation of cerebral white matter hyperintensities using only 3D FLAIR images.

Simões R, Mönninghoff C, Dlugaj M, Weimar C, Wanke I, van Cappellen van Walsum AM, Slump C.

Magn Reson Imaging. 2013 Sep;31(7):1182-9. doi: 10.1016/j.mri.2012.12.004. Epub 2013 May 16.

PMID:
23684961
35.

Association of aneurysms and variation of the A1 segment.

Krasny A, Nensa F, Sandalcioglu IE, Göricke SL, Wanke I, Gramsch C, Sirin S, Oezkan N, Sure U, Schlamann M.

J Neurointerv Surg. 2014 Apr 1;6(3):178-83. doi: 10.1136/neurintsurg-2013-010669. Epub 2013 Apr 23.

PMID:
23612892
36.

Glucose regulates secretion of exogenously expressed insulin from HepG2 cells in vitro and in a mouse model of diabetes mellitus in vivo.

Liu YY, Jia W, Wanke IE, Muruve DA, Xiao HP, Wong NC.

J Mol Endocrinol. 2013 Apr 12;50(3):337-46. doi: 10.1530/JME-12-0239. Print 2013 Jun.

PMID:
23475748
37.

[3-year follow-up after endovascular aneurysm treatment with Silk® flow diverter].

Ringelstein A, Schlamann M, Goericke SL, Mönninghoff C, Sandalcioglu IE, El Hindy N, Forsting M, Wanke I.

Rofo. 2013 Apr;185(4):328-32. doi: 10.1055/s-0032-1330353. Epub 2013 Feb 18. German.

38.

Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation.

Wanke I, Skabytska Y, Kraft B, Peschel A, Biedermann T, Schittek B.

Exp Dermatol. 2013 Feb;22(2):153-5. doi: 10.1111/exd.12083.

PMID:
23362876
39.

Neuroform stent-assisted treatment of intracranial aneurysms: long-term follow-up study of aneurysm recurrence and in-stent stenosis rates.

Kulcsár Z, Göricke SL, Gizewski ER, Schlamann M, Sure U, Sandalcioglu IE, Ladd S, Mummel P, Kastrup O, Forsting M, Wanke I.

Neuroradiology. 2013 Mar;55(4):459-65. doi: 10.1007/s00234-013-1143-z. Epub 2013 Jan 29.

PMID:
23358878
40.

Flow diversion treatment: intra-aneurismal blood flow velocity and WSS reduction are parameters to predict aneurysm thrombosis.

Kulcsár Z, Augsburger L, Reymond P, Pereira VM, Hirsch S, Mallik AS, Millar J, Wetzel SG, Wanke I, Rüfenacht DA.

Acta Neurochir (Wien). 2012 Oct;154(10):1827-34. doi: 10.1007/s00701-012-1482-2. Epub 2012 Aug 29.

41.

Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N.

Acta Neurochir Suppl. 2013;115:27-31. doi: 10.1007/978-3-7091-1192-5_7.

PMID:
22890639
42.

Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.

Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, Möller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group.

Stroke. 2012 Sep;43(9):2336-42. Epub 2012 Jun 26.

PMID:
22738922
43.

Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N.

Stroke. 2012 Jun;43(6):1463-9. doi: 10.1161/STROKEAHA.111.648980. Epub 2012 Mar 8. Erratum in: Stroke. 2012 Jul;43(7):e68.

PMID:
22403047
44.

Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.

Weber R, Weimar C, Wanke I, Möller-Hartmann C, Gizewski ER, Blatchford J, Hermansson K, Demchuk AM, Forsting M, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group.

Stroke. 2012 Feb;43(2):350-5. doi: 10.1161/STROKEAHA.111.631739. Epub 2012 Jan 19.

45.

Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat.

Paulmann M, Arnold T, Linke D, Özdirekcan S, Kopp A, Gutsmann T, Kalbacher H, Wanke I, Schuenemann VJ, Habeck M, Bürck J, Ulrich AS, Schittek B.

J Biol Chem. 2012 Mar 9;287(11):8434-43. doi: 10.1074/jbc.M111.332270. Epub 2012 Jan 18.

46.

MELAS/SANDO overlap syndrome associated with POLG1 mutations.

Hansen N, Zwarg T, Wanke I, Zierz S, Kastrup O, Deschauer M.

Neurol Sci. 2012 Feb;33(1):209-12. doi: 10.1007/s10072-011-0631-3. Epub 2011 Jun 7. No abstract available.

PMID:
21647632
47.

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N.

Lancet Neurol. 2011 Jul;10(7):618-25. doi: 10.1016/S1474-4422(11)70108-9. Epub 2011 Jun 2.

PMID:
21640651
48.

The management of arteriovenous malformations.

Sandalcioglu IE, Wanke I, Zappala V, Forsting M, Sure U.

J Neurosurg Sci. 2011 Mar;55(1):57-69. Review.

PMID:
21464810
49.

The pipeline embolization device for the intracranial treatment of aneurysms trial.

Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D.

AJNR Am J Neuroradiol. 2011 Jan;32(1):34-40. doi: 10.3174/ajnr.A2421. Epub 2010 Dec 9.

50.

Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment.

Kulcsár Z, Houdart E, Bonafé A, Parker G, Millar J, Goddard AJ, Renowden S, Gál G, Turowski B, Mitchell K, Gray F, Rodriguez M, van den Berg R, Gruber A, Desal H, Wanke I, Rüfenacht DA.

AJNR Am J Neuroradiol. 2011 Jan;32(1):20-5. doi: 10.3174/ajnr.A2370. Epub 2010 Nov 11.

Supplemental Content

Support Center